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Background: Because previous studies have indicated that otitis media may be a polymicrobial disease, we
prospectively analyzed middle ear effusions of children undergoing tympanostomy tube placement with multiplex
polymerase chain reaction for four otopathogens.
Methods: Middle ear effusions from 207 children undergoing routine tympanostomy tube placement were
collected and were classified by the surgeon as acute otitis media (AOM) for purulent effusions and as otitis media
with effusion (OME) for non-purulent effusions. DNA was isolated from these samples and analyzed with multiplex
polymerase chain reaction for Haemophilus influenzae, Streptococcus pneumoniae, Alloiococcus otitidis, and Moraxella
catarrhalis.
Results: 119 (57%) of 207 patients were PCR positive for at least one of these four organisms. 36 (30%) of the
positive samples indicated the presence of more than one bacterial species. Patient samples were further separated
into 2 groups based on clinical presentation at the time of surgery. Samples were categorized as acute otitis media
(AOM) if pus was observed behind the tympanic membrane. If no pus was present, samples were categorized as
otitis media with effusion (OME). Bacteria were identified in most of the children with AOM (87%) and half the
children with OME (51%, p< 0.001). A single bacterial organism was detected in middle ear effusions from children
with AOM more often than those with OME (74% versus 33%, p< 0.001). Haemophilus influenzae was the
predominant single organism and caused 58% of all AOM in this study. Alloiococcus otitidis and Moraxella catarrhalis
were more frequently identified in middle ear effusions than Streptococcus pneumoniae.
Conclusions: Haemophilus influenzae, Streptococcus pneumoniae, Alloiococcus otitidis, and Moraxella catarrhalis were
identified in the middle ear effusions of some patients with otitis media. Overall, we found AOM is predominantly a
single organism infection and most commonly from Haemophilus influenzae. In contrast, OME infections had a more
equal distribution of single organisms, polymicrobial entities, and non-bacterial agents.Background
Otitis media is one of the most common childhood dis-
eases [1]. Acute otitis media (AOM) typically exhibits
rapid-onset purulent middle ear effusion and symptoms
of middle ear inflammation, including fever and otalgia
[2], whereas otitis media with effusion (OME) exhibits
non-purulent middle ear effusion in the absence of
symptoms of acute infection [3]. Otitis media is the* Correspondence: sreid@wakehealth.edu
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reproduction in any medium, provided the orleading reason for pediatric office visits and for anti-
biotic prescriptions [4]. The economic burden of otitis
media in the United States is estimated at $3–5 billion
in direct annual costs [5,6], and much higher if indirect
costs such as lost working days and loss of productivity
by family members caring for the sick are included [7].
A common treatment for frequent AOM and for
persistent OME with hearing loss is the insertion of tym-
panostomy tubes. Insertion of tympanostomy tubes is
the most common surgical procedure excluding circum-
cision for U.S. children ≤15 years of age [8,9]. Parents of
children who have undergone tympanostomy tubeLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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elimination of AOM symptoms and improved hearing
and speech [10].
The bacterial pathogens most commonly cultured from
the middle ear effusions of children with AOM are H.
influenzae, S. pneumoniae, and M. catarrhalis [11,12].
Although routine bacterial cultures have been the conven-
tional method to identify the etiology of AOM, approxi-
mately 35% of these bacterial cultures are negative [13-15].
Polymerase chain reaction (PCR) has detected bacterial
DNA in culture-negative middle ear effusions [16,17]. PCR
not only provides a more sensitive method for identi-
fying MEE pathogens, but it also allows for the identifi-
cation of fastidious or slow-growing organisms. For
example, A. otitidis, a pathogen first isolated from middle
ear effusions of children with OME [18], was more
recently identified because its slow growth character-
istics are not conducive to identification using conven-
tional bacterial culture methods [13]. The sensitivity
of PCR has lead to a growing recognition that otitis
media may be a polymicrobial disease [19]. Here we
used a multiplex PCR to determine the prevalence of
four known otopathogens (H. influenzae, S. pneumoniae,
A. otitidis, and M. catarrhalis) in the middle ear effu-
sions of children undergoing routine tympanostomy
placement.
Methods
Patients and sample collection
Effusion samples were collected from all children (< 18 y)
who had tympanostomy tube placement for clinical
indications at Wake Forest School of Medicine from
July 2009 through December 2010 provided middle ear
fluid was present at the time of surgery. The principle
pre-operative diagnoses were recurrent acute otitis
media and chronic otitis media with effusion. These are
the two principle indications for which children undergo
myringotomy and tympanostomy tube placement. The
children from whom samples were collected are represen-
tative of all children who undergo myringotomy and tym-
panostomy tube placement at Wake Forest. This study
was reviewed and approved by the Wake Forest School of
Medicine Institutional Review Board as an exempt study;
no personal health information was collected and dis-
carded samples of middle ear effusions were evaluated for
bacterial pathogens.
Children who at the time of tympanostomy tube place-
ment had middle ear effusions had that fluid aspirated
into a sterile trap. Middle ear effusion samples were
categorized as AOM or OME by the surgeon at the time
of tympanostomy tube placement. AOM was diagnosed
by the identification of purulent fluid behind the tym-
panic membrane upon myringotomy. OME was defined
as non-purulent fluid behind the tympanic membrane.All middle ear effusion samples were kept at room
temperature and transported to the research laboratory
within 2 h. Samples were then refrigerated at 4°C until
DNA isolation. All data was prospectively acquired.
While a formal blind was not used, specimen processing
was done without prior record review. Once samples
were collected, surgeons were not involved in specimen
processing.
Isolation of DNA
For the few effusions that were very viscous, they were
placed in Lysing Matrix D tubes (MP Biomedical, Solon,
OH) with 500μL of 1X TE buffer (pH 7.5). The lysing
tubes were processed in a FastPrep FP120 homogenizer
(Thermo Electron Corporation, Milford, MA) for 40 s on
a setting of 6.0. Processed samples were centrifuged at
12000 rpm for 5 min and 200μL of supernatant were used
as the starting material for genomic DNA extraction.
DNA was isolated from middle ear effusions using a
conventional genomic DNA extraction protocol. First,
200μL of effusion were treated with 15μL of Mutanolysin
(10U/μL; Sigma, St. Louis, MO) and 21μL of Lysozyme
(20 mg/mL; Amresco, Solon, OH) and then incubated at
37°C for 1 h. Second, samples were treated with 55μL of
10% SDS (EMD, Gibbstown, NJ) and 68μL of RNAse A
(Sigma, St. Louis, MO) and then incubated at 37°C for
1 h. Third, samples were treated with 10μL of Proteinase
K (10 mg/mL; Amresco, Solon, OH) and then incubated
at 37°C for 1 h. Fourth, samples were treated with 55μL of
5 M NaCl (Sigma, St. Louis, MO) and 50μL of prewarmed
(to 60°C) 10% Hexadecyltrimethyl-ammonium bromide
(Sigma, St. Louis, MO) and then incubated at 60°C for 20
min. Fifth, samples were mixed with 470μL of Phenol:
Chloroform:Isoamyl Alcohol (25:24:1; Sigma, St. Louis,
MO) and transferred to prespun Phase Lock Tubes (2 mL,
heavy; 5 Prime, Gaithersburg, MD). Tubes were centri-
fuged for 5 min at 12000 rpm, and the upper (aqueous)
layer from each sample was transferred to a sterile 1.5 mL
microcentrifuge tube. Aqueous layers were mixed with
50μL of 3 M NaOAc (Sigma, St. Louis, MO) and 470μL of
ice cold 100% Ethanol (Warner-Graham, Cockeysville,
MD). Samples were incubated at −20°C for a minimum of
30 min. Precipitated samples were centrifuged for 30 min
at 12000 rpm at 4°C. Supernatants were discarded and
pellets washed with 1 mL of 70% Ethanol. Pellets were
allowed to completely dry and were resuspended in a final
volume of 100μL of dH2O.
Polymerase chain reaction
A multiplex PCR procedure was performed to simultan-
eously detect H. influenzae, S. pneumoniae, A. otitidis, and
M. catarrhalis with minor modifications of the methods
described by Hendolin et al. [20]. Briefly, PCR extension
steps were performed at 65°C with HotMasterMix (5 Prime,
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H. influenzae 86–028, S. pneumoniae TIGR4, A. otitidis
SS1337, and M. catarrhalis 7169 were used as positive
controls for PCR (Figure 1). Results were visualized using
agarose gel electrophoresis (2.5% agarose, 100 V for 3 h)
and ethidium bromide staining (500 ng/mL final ethidium
bromide concentration).
Chart review
The demographic characteristics, current medications,
and past medical history were all determined by chart re-
view performed at the time of surgery without collecting
any personal health identifiers. The pediatric otolaryngolo-
gist used a standardized clinical form that elicited all of
this clinical information by history and/or by documenta-
tion from the primary care provider. Previous antibiotics
were documentation of any course of antibiotics within
6 months of surgery.
Analyses
The frequency of demographic characteristics, clinical
characteristics, or microbiologic results of children with
AOM and OME middle ear effusions were compared
using chi-square analyses or Fisher’s exact tests. For the
children who had middle ear effusions in both ears, the
results from each ear were combined so that all children
with one or two middle ear effusions had one result.
Identification of purulence in the effusion of at least one
ear was used as a basis for categorizing the sample as
AOM. STATA 8.1 was used for all statistical analyses.
Results
The study population comprised 207 children undergo-
ing tympanostomy tube placement for clinical indica-
tions at Wake Forest School of Medicine from July 2009
to December 2010. Two-thirds of the study population
was male, half were 1–3 years of age, and 60% were Cau-
casian (Table 2). Children with AOM at tympanostomy
were more likely to be younger, to have had previous ear
infections, or to have been treated with antibiotics in the
previous 6 months than children with OME at tympa-
nostomy. In contrast, children with OME were more
likely to have had an adenoidectomy than children with
AOM.Table 1 Primers used in multiplex PCR
Primer Name Nucleotide Sequ
H. influenzae FWD 5′-CGTATTATCGGAAGAT
S. pneumoniae FWD 5′-AAGGTGCACTTGCAT
A. otitidis FWD 5′-GGGGAAGAACACGG
M. catarrhalis FWD 5′-CCCATAAGCCCTGA
Universal REV 5′-CTACGCATTTCACCG
aWhen the designated FWD primer is used in conjunction with the Universal REV pEffusions from 119 (57%) of 207 children were PCR
positive for H. influenzae, S. pneumoniae, A. otitidis,
and/or M. catarrhalis. Of these 119 PCR positive sam-
ples, 36 (30%) had 2–4 bacterial species detected
(Figure 2, Table 3, Additional file 1: Table S1). Bacteria
were identified in 33 (87%) of 38 children with AOM
as compared to 86 (51%) of 169 children with OME
(p< 0.001). Single bacterial species were identified in
the majority of children with AOM and a minority of
children with OME (74% versus 33%, p< 0.001). Identi-
fying multiple bacterial pathogens was similar for chil-
dren with AOM and OME (13% versus 18%, p = 0.64),
whereas not identifying any of the four bacterial patho-
gens was less common for AOM than OME (13% versus
49%, p< 0.001).
For middle ear effusions with a single bacterial species
identified, the etiology for children with AOM differed
significantly from those with OME (p< 0.001). H. influ-
enzae accounted for 79% of the isolates from children
with AOM, whereas three bacteria accounted for the
majority of isolates for children with OME: H .influenzae
for 36%, A. otitidis for 40% and M. catarrhalis for 20%.
S. pneumoniae was detected in 5% of all isolates for chil-
dren with AOM and OME. Alloiococcus otitidis was
identified either as a single organism or as a polymicro-
bial component in 18% of AOM and 25% of OME. All
four bacteria were identified in at least one of the middle
ear effusions with AOM or OME.
Discussion
Using a multiplex PCR to simultaneously detect four
bacterial otopathogens in the middle ear effusions
obtained from children undergoing routine tympanost-
omy tube placement, we found distinct bacterial profiles
for AOM and OME. Bacteria were identified in most of
the children with AOM (87%) and half the children with
OME (51%, p< 0.001). A single bacterial organism was
detected in middle ear effusions from patients with
AOM more often than those with OME (74% versus
33%, p< 0.001). Haemophilus influenzae was the pre-
dominant single organism and caused 58% of all AOM
in this study. Alloiococcus otitidis and Moraxella catar-
rhalis were more frequently identified in middle ear
effusions than Streptococcus pneumoniae.ence Predicted Amplicon Sizea
GAAAGTGC-3′ 525 base pairs
CACTACC-3′ 484 base pairs
ATAGGA-3′ 264 base pairs
CGTTAC-3′ 237 base pairs
CTACAC-3′
rimer.

















<1 33 (16) 5 (13) 28 (17) 0.03
1–3 103 (50) 25 (66) 78 (46)
>3 69 (33) 7 (18) 62 (37)
Gender
Male 139 (67) 21 (55) 118 (70) 0.09
Female 68 (33) 17 (45) 51 (30)
Race
White 123 (60) 29 (76) 94 (56) 0.09
Black 44 (21) 5 (13) 39 (23)
Hispanic 36 (17) 3 (8) 33 (20)
Other 2 (1) 0 (0) 2 (1)
Currently on Antibioticsa
Yes 26 (13) 7 (18) 19 (11) 0.27
No 179 (86) 30 (79) 149 (88)
Currently on Allergy Medicinesb
Yes 44 (21) 8 (21) 36 (21) 1.00
No 160 (77) 30 (79) 130 (77)
Previous Ear Infections
Yes 145 (70) 33 (87) 112 (66) 0.008
No 57 (28) 4 (11) 53 (31)
Previously on Antibioticsc
Yes 100 (48) 26 (68) 74 (44) 0.007
No 107 (52) 12 (32) 95 (56)
Adenoidectomy
Yes 16 (8) 0 (0) 16 (9) 0.046
No 186 (90) 38 (100) 148 (88)
Previous Ear Tubes
Yes 49 (24) 6 (16) 43 (25) 0.21
No 153 (74) 32 (84) 121 (72)
Cleft Palate
Yes 9 (4) 1 (3) 8 (5) 1.00
No 189 (91) 37 (97) 152 (90)
aCurrent antibiotics include: Amoxicillin, Amoxicillin + Clavulanic Acid,
Azithromycin, Cefdinir, Cefpodoxime, Cefprozil, Sulfamethoxazole.
bCurrent allergy medicines include: Budesonide, Cetirizine, Clemastine,
Diphenhydramine, Fexofenadine, Fluticasone, Levocetirizine, Loratadine,
Mometasone, Montelukast, Olopatadine.
cPrevious antibiotics include: Amoxicillin, Amoxicillin + Clavulanic Acid,
Azithromycin, Cefdinir, Cefpodoxime, Cefprozil, Ceftriaxone, Cefuroxime,
Ciprofloxacin, Clindamycin, Sulfamethoxazole.
Figure 1 Multiplex PCR Results. Multiplex PCR products were
electrophoresed on 2.5% agarose. Hi, Haemophilus influenzae
control band, expected size 525 bp; Sp, Streptococcus pneumoniae
control band, expected size 484 bp; Ao, Alloiococcus otitidis control
band, expected size 264 bp; Mc, Moraxella catarrhalis control band,
expected size 237 bp; 265L, 269R, 246R, and 248L, experimental
samples; bp, base pair.
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ganism infection, whereas, OME infections had a more
equal distribution of single organisms, polymicrobial en-
tities, and non-bacterial agents.
H. influenzae was the predominant bacterial species
identified, comprising 66% (25 of 38) of middle ear effu-
sions with AOM and 24% (40 of 169) of middle ear effu-
sions with OME. We observed a higher proportion of
samples with H. influenzae and a lower proportion with
S. pneumoniae than what has been previously reported.
Kaur et al., using a similar multiplex PCR approach on
AOM middle ear effusion, detected H. influenzae in 31%
of children who were on antibiotic prior to sample ac-
quisition and 39% in children who had not undergone
antibiotic treatment [13]. However, Kaur et al. utilized
specifically culture-negative MEF, a distinction we have
not made with the samples obtained for our research. In
other work using culture-negative AOM MEE samples,
Xu et al. observed an H. influenzae percentage of 24%
[21].
While the levels of H. influenzae in our patients appear
to be higher than what others have seen, we observed the
opposing trend with respect to S. pneumoniae. S. pneumo-
niae, regarded as one of the 3 most prevalent bacterial con-
tributors to OM infection, was identified in only 2 of 38
AOM patients (~5%) and 8 of 169 OME patients (~5%). In
the studies listed above by Kaur et al. and Xu et al., S.
pneumoniae was identified in around 38%–57% of culture-
negative AOM MEF samples, percentages that are consid-
erably higher than what was observed in our study [13,21].A number of factors may explain our finding that S.
pneumoniae was detected in only 5% of all study subjects.
Published studies of pneumococcal prevalence in otitis
media report a wide incidence range. Brooke et al. used
standard culture based techniques to detect S. pneumoniae
~1000 pneumatic Eustachian tube procedures per year
207 fluid present at time of pneumatic Eustachian tube procedure
38 (18%) purulent fluid 
(acute otitis media)
169 (82%) non-purulent fluid 
(middle ear effusion)
33 (87%) positive PCR 5 (13%) negative PCR 86 (51%) positive PCR 83 (49%) negative PCR
28 (85%) single organism 5 (15%) polymicrobial 55 (64%) single organism 31 (36%) polymicrobial
Figure 2 Flow Chart of PCR Analysis.
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used PCR to detect S. pneumoniae in OME effusions at a
higher percentage of approximately 30% [23]. Research
conducted by Hendolin et al. detected S. pneumoniae in







(column %) (n = 38)
No. of Children




Single organism 22 (58) 20 (12) <0.001
Polymicrobial
component
3 (8) 20 (12)
None 13 (34) 129 (76)
Streptococcus
pneumoniae
Single organism 1 (3) 2 (1) 0.79
Polymicrobial
component
1 (3) 6 (4)
None 36 (95) 161 (95)
Alloiococcus otitidis
Single organism 2 (5) 22 (13) 0.40
Polymicrobial
component
5 (13) 21 (12)
None 31 (82) 126 (75)
Moraxella catarrhalis
Single organism 3 (8) 11 (7) 0.95
Polymicrobial
component
4 (11) 18 (11)
None 31 (82) 140 (83)
Overall
Single organism 28 (74) 55 (33) <0.001
Polymicrobial 5 (13) 31 (18)
No Bacteria
Detected
5 (13) 83 (49)
*Percent totals may not add up to 100% due to rounding error.multiplex PCR primers used by Hendolin et al. Kaur et al.
used these PCR primers to identify S. pneumoniae in ap-
proximately 57% of effusions from children with AOM
[13], and this data does not suggest that our PCR assay has
a low sensitivity for detection of pneumococcus.
The low S. pneumoniae incidence found in our study
might be explained by the effectiveness of pneumococcal
conjugate vaccination. A heptavalent pneumococcal conju-
gate vaccine (PCV7) was introduced in 2000, and since its
acceptance for widespread use there has been a shift in the
incidence of otitis media pathogens. In the years immedi-
ately following PCV7 introduction, H. influenzae emerged
as the most common AOM isolate [14,24]. More recently,
S. pneumoniae serotypes not included in the PCV7 vaccine
have been increasingly isolated from AOM cases [12]. In
2010, a new modified pneumococcal conjugate vaccine was
introduced to combat the emergence of S. pneumoniae ser-
otypes not included in the original PCV7 vaccine. It con-
tained components from 13 serotypes of S. pneumoniae (7
serotypes included in the PCV7 vaccine along with 6 re-
cently emerging serotypes). Our findings are consistent
with improved pneumococcal vaccine prevention in chil-
dren enrolled in this study.
Another interesting result was the high incidence of A.
otitidis in our OME samples (approximately 25%, single
and co-infections included). A. otitidis was first identified in
OME samples by Faden et al. [18]. It is a Gram-positive
organism that exhibits very slow growth, making it very dif-
ficult to identify through standard culture techniques. It has
been thought of as solely an OME pathogen; however, it is
increasingly recognized as a pathogen in AOM [13,25,26].
Our findings support what has been reported previously in
OME cases [20]. The A. otitidis results further demonstrate
the importance of using methods other than standard cul-
ture for the identification of fastidious otopathogens.
Conclusions
In conclusion, the etiology of OM appears to revolve
around disease type (AOM or OME). A multiplex PCR
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species in effusions from children experiencing OM. The
PCR procedures can overcome the obstacles of culturing
fastidious organisms, and may offer a more sensitive and
time efficient method for evaluating middle ear effu-
sions. While our approach targeted 4 organisms, the
method could be adapted for the identification of add-
itional microorganisms.
Our criterion for separating AOM cases from OME
cases was the presence of pus behind the tympanic mem-
brane at the time of tympanostomy tube placement. The
results of our research clearly show that this single easily
observable patient difference was sufficient to categorize
disease condition into 2 distinct populations. Moreover,
our results indicate that when AOM is observed there is
usually a single bacterial etiology. Culture or PCR analysis
of pus at tympanostomy tube placement may be especially
useful in guiding antibiotic therapy.
Additional file
Additional file 1. Supplemental Table 1: Incidence of Bacterial DNA
Presence in Middle Ear Effusions.
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